In this dissertation the transcription factor Prrx1 was identified to modulate fibroblast plasticity in pancreatic cancer. Characterizing the functionality of Prrx1 in cancer-associated fibroblasts, genetic engineered mouse models were used. The in vivo findings demonstrate that Prrx1 in CAFs restrains stromal expansion but promotes invasion of tumor cells. Both the in vivo and in vitro experiments show that targeting fibroblast plasticity directly changes the fibroblast-tumor cell interaction, the stroma contribution, and therefore the progression of the disease.
«
In this dissertation the transcription factor Prrx1 was identified to modulate fibroblast plasticity in pancreatic cancer. Characterizing the functionality of Prrx1 in cancer-associated fibroblasts, genetic engineered mouse models were used. The in vivo findings demonstrate that Prrx1 in CAFs restrains stromal expansion but promotes invasion of tumor cells. Both the in vivo and in vitro experiments show that targeting fibroblast plasticity directly changes the fibroblast-tumor cell interaction,...
»